Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential pres...
The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 p...
Singapore: Researchers from Cuba have developed a new vaccine for treatment of chronic hepatitis B. The vaccine HeberNas...
Singapore: GlaxoSmithKline has received a positive opinion for its Malaria vaccine candidate from the Committee for Medi...
Singapore: US-based Novavax recently announced that its experimental candidate vaccine for Ebola showed promise in early...
Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a...
Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign ma...
Singapore: WHO and United Nations World Food Program (WFP) have come together to build logistics strength for Ebola-affe...
Singapore: The US FDA has approved Sanofi Pasteur supplemental biologics license application (sBLA) for its four-strain ...
Singapore: With no cure or vaccine available for AIDS, that is spreading across the globe like a wide epidemic, billiona...
Singapore: Investment in HIV prevention research has declined posing a challenge to the pipeline of HIV prevention produ...
Singapore: Novartis has announced that it has completed the divestiture of its influenza vaccine unit to CSL Limited. Th...
Singapore: Bringing new hope to millions of people worldwide, the experimental HIV vaccine developed by Johnson & Jo...
Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology I...
Singapore: Scientists at Stanford University, US, and Leiden University Medical Center in the Netherlands, have tested a...
Merck has announced that the European Commission has approved KEYTRUDA (pembrolizumab), its anti-PD-1 therapy, for the ...
Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio ...
Healthcare stakeholders are keeping high hopes with the successful results of Sanofi Pasteur's Phase III trial of dengue...
